- Report
- January 2025
- 429 Pages
Global
From €4377EUR$4,950USD£3,776GBP
- Report
- May 2025
- 180 Pages
Global
From €3135EUR$3,545USD£2,704GBP
€3483EUR$3,939USD£3,004GBP
- Report
- April 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,425GBP
- Report
- March 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,425GBP
- Report
- August 2024
- 150 Pages
Global
From €3316EUR$3,750USD£2,860GBP
- Report
- August 2024
- 150 Pages
Global
From €3316EUR$3,750USD£2,860GBP
- Report
- June 2025
- 150 Pages
Global
From €3404EUR$3,850USD£2,937GBP
- Report
- March 2025
- 89 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- January 2025
- 81 Pages
Global
From €3500EUR$4,240USD£3,125GBP
- Report
- July 2024
- 150 Pages
Global
From €3316EUR$3,750USD£2,860GBP
- Report
- May 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,165GBP
- Report
- May 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,165GBP
- Report
- May 2022
- 140 Pages
Global
From €3183EUR$3,600USD£2,746GBP
- Report
- October 2021
- 101 Pages
Global
From €3537EUR$4,000USD£3,051GBP
- Report
- October 2021
- 311 Pages
Global
From €3537EUR$4,000USD£3,051GBP
The Impella market is a segment of the cardiovascular device industry that focuses on the development and production of mechanical circulatory support systems. These systems are designed to provide temporary support for the heart, allowing it to rest and recover from a variety of conditions. Impella devices are typically used in the treatment of acute heart failure, cardiogenic shock, and other conditions that require short-term circulatory support.
The Impella market is highly competitive, with a number of companies offering a range of products. These include Abiomed, Medtronic, St. Jude Medical, and Terumo Corporation. Other companies in the market include Berlin Heart, CardiacAssist, and SynCardia Systems. Show Less Read more
